These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21709210)

  • 21. Status of uric acid management in hypertensive subjects.
    Yamamoto Y; Matsubara K; Igawa G; Kaetsu Y; Sugihara S; Matsuura T; Ando F; Sonoyama K; Hamada T; Ogino K; Igawa O; Shigemasa C; Hisatome I
    Hypertens Res; 2007 Jun; 30(6):549-54. PubMed ID: 17664859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective and mixed endothelin receptor antagonism in cardiovascular disease.
    Dhaun N; Pollock DM; Goddard J; Webb DJ
    Trends Pharmacol Sci; 2007 Nov; 28(11):573-9. PubMed ID: 17950470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Uric acid and kidneys – Physiological and pathophysiological aspects].
    Kim MJ; Mayr M
    Ther Umsch; 2016; 73(3):167-75. PubMed ID: 27008450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Uric acid and the development of hypertension.
    Hwu CM; Lin KH
    Med Sci Monit; 2010 Oct; 16(10):RA224-30. PubMed ID: 20885365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What are the key arguments against uric acid as a true risk factor for hypertension?
    Johnson RJ; Sánchez-Lozada LG; Mazzali M; Feig DI; Kanbay M; Sautin YY
    Hypertension; 2013 May; 61(5):948-51. PubMed ID: 23460277
    [No Abstract]   [Full Text] [Related]  

  • 26. Uric acid levels and the risk of Contrast Induced Nephropathy in patients undergoing coronary angiography or PCI.
    Barbieri L; Verdoia M; Schaffer A; Cassetti E; Marino P; Suryapranata H; De Luca G;
    Nutr Metab Cardiovasc Dis; 2015 Feb; 25(2):181-6. PubMed ID: 25315668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Hyperuricemia].
    Chizyński K; Rózycka M
    Pol Merkur Lekarski; 2005 Nov; 19(113):693-6. PubMed ID: 16498814
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between serum uric acid and mortality in a Chinese population of hypertensive patients.
    Wang J; Wang Y; Zhao D; Guo X; Zhong JQ
    Ren Fail; 2015 Feb; 37(1):73-6. PubMed ID: 25260057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of mild hyperuricemia on urinary transforming growth factor beta and the progression of chronic kidney disease.
    Talaat KM; el-Sheikh AR
    Am J Nephrol; 2007; 27(5):435-40. PubMed ID: 17622758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An allopurinol-controlled, randomized, double-dummy, double-blind, parallel between-group, comparative study of febuxostat (TMX-67), a non-purine-selective inhibitor of xanthine oxidase, in patients with hyperuricemia including those with gout in Japan: phase 3 clinical study.
    Kamatani N; Fujimori S; Hada T; Hosoya T; Kohri K; Nakamura T; Ueda T; Yamamoto T; Yamanaka H; Matsuzawa Y
    J Clin Rheumatol; 2011 Jun; 17(4 Suppl 2):S13-8. PubMed ID: 21654265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Gout and chronic kidney disease.
    Keller DL
    Cleve Clin J Med; 2011 Feb; 78(2):81; author reply 81-2. PubMed ID: 21370528
    [No Abstract]   [Full Text] [Related]  

  • 32. Dual ET(A)/ET(B) vs. selective ET(A) endothelin receptor antagonism in patients with pulmonary hypertension.
    Opitz CF; Ewert R
    Eur J Clin Invest; 2006 Sep; 36 Suppl 3():1-9. PubMed ID: 16919004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperuricemia, gout and the kidney.
    Gibson T
    Curr Opin Rheumatol; 2012 Mar; 24(2):127-31. PubMed ID: 22157498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endothelin receptor antagonists improve exercise tolerance and oxygen saturations in patients with Eisenmenger syndrome and congenital heart defects.
    Mehta PK; Simpson L; Lee EK; Lyle TA; McConnell ME; Book WM
    Tex Heart Inst J; 2008; 35(3):256-61. PubMed ID: 18941642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelin receptor antagonism and renin inhibition as treatment options for scleroderma kidney.
    Dhaun N; MacIntyre IM; Bellamy CO; Kluth DC
    Am J Kidney Dis; 2009 Oct; 54(4):726-31. PubMed ID: 19376621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hyperuricemia and the problem of chronic kidney disease].
    Shcherbak AV; Kozlovskaia LV; Bobkova IN; Balkarov IM; Lebedeva MV; Stakhova TIu
    Ter Arkh; 2013; 85(6):100-4. PubMed ID: 23875201
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of hyperuricemia in essential hypertension.
    Trachtman H
    Hypertension; 2007 Jun; 49(6):e45; author reply e46. PubMed ID: 17389252
    [No Abstract]   [Full Text] [Related]  

  • 38. Selective or nonselective endothelin receptor blockade in pulmonary arterial hypertension.
    Wilkins MR
    Am J Respir Crit Care Med; 2004 Feb; 169(4):433-4. PubMed ID: 14766656
    [No Abstract]   [Full Text] [Related]  

  • 39. [Serum uric acid--a cardiovasular risk factor?].
    Alderman M; Redfern JS
    Ther Umsch; 2004 Sep; 61(9):547-52. PubMed ID: 15493113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quercetin lowers plasma uric acid in pre-hyperuricaemic males: a randomised, double-blinded, placebo-controlled, cross-over trial.
    Shi Y; Williamson G
    Br J Nutr; 2016 Mar; 115(5):800-6. PubMed ID: 26785820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.